Visual estimations of the completeness of revascularization failed to predict subsequent cardiovascular events for patients with acute coronary syndromes (ACS) who underwent stenting guided by fractional flow reserve (FFR), researchers reported in the Journal of the American College of Cardiology.

The American Heart Association has tightened its guidelines for diagnosing resistant hypertension—a condition that affects up to 15 percent of patients treated for high blood pressure—according to a scientific statement published this month.

Sustained elevated blood pressure can increase a patient’s risk for both aortic valve stenosis and aortic regurgitation, according to an analysis of 5.4 million non-CVD patients in the U.K.

Scientists have developed a wearable ultrasound device to measure central blood pressure (BP). It performed as well as a current noninvasive technique upon testing, according to a press release.

Carcinogen-containing valsartan products that were recalled in about two dozen countries over the past few months didn’t significantly raise cancer risk in the short term, according to a Danish registry study published online Sept. 12 in The BMJ.

As extreme weather hits the East Coast this weekend, residents are stocking up on nonperishables, buying batteries in bulk and boarding up windows. But storm preparation looks a little different for diabetics, who are forced to consider their medical needs weeks in advance, Everyday Health reports.

The concept of “time in range” has been used in warfarin monitoring and glycemic management for diabetic patients, but why hasn't it caught on as a useful metric in controlling hypertension?

Cerner and Duke Clinical Research Institute have teamed up to develop a new CVD risk calculator app, the companies announced late this summer—a move they hope will improve shared decision-making between physicians and their patients.